Work

Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis

Year: 1995

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Neurology

DOI: 10.1002/ana.410370108

Authors: Donald E. Goodkin, Richard A. Rudick, Sharon Vanderbrug Medendorp, Michele M. Daughtry, Kathleen M. Schwetz, Jill Fischer, Carolyn van Dyke

Institutions: University of California, San Francisco, Cleveland Clinic

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2167365151

FWCI: 16.93

Cites: 50

Cited by: 305

Related to: 9